Trial Information
Current as of January 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how people’s thinking and memory skills change after experiencing their first ischemic stroke, which is a type of stroke caused by a blockage in the blood vessels supplying the brain. The researchers want to understand the different ways that these skills can improve or decline over time in different individuals. If you or a family member is between 18 and 74 years old and has recently had your first ischemic stroke, you might be eligible to participate in this study.
Participants will be enrolled within 10 days of the stroke and will undergo cognitive testing to assess their mental performance. It’s important to note that individuals with a history of previous strokes, certain medical conditions, or those who cannot undergo MRI scans may not qualify for the study. The trial is currently recruiting participants, and those who join can contribute to important research that could help improve care for stroke survivors in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years old
- • First-ever anterior circulation ischemic stroke confirmed by routine MRI
- • Time of enrollment: ≤ 10 days from stroke onset.
- Exclusion Criteria:
- • Previous stroke anamnestic or based on clinical imaging
- • Additional stroke in posterior circulation
- • Conditions that preclude the cognitive testing (e.g. delirium, intubation, reduced vigilance
- • Neurological or psychiatric conditions that preclude the data interpretation (e.g. pre-stroke dementia, schizophrenia, brain tumor, regular intake of benzodiazepine, depression)
- • MRI contraindication
- • Native language other than German, French or Italian
Trial Officials
Roza M. Umarova, PD Dr.
Principal Investigator
Department of Neurology, Inselspital, University Hospital Bern, University of Bern
About Roza Umarova
Roza Umarova is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. With a commitment to improving patient outcomes, Roza Umarova oversees the design, implementation, and management of clinical trials across various therapeutic areas. Leveraging a strong network of healthcare professionals and cutting-edge technology, the organization aims to ensure compliance with regulatory standards while fostering collaboration and transparency throughout the research process. Roza Umarova is dedicated to contributing to the scientific community and enhancing the quality of care through evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials